Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group

Blood (2020) 136 (Supplement 1): 6–8.

https://doi.org/10.1182/blood-2020-141872

Published: 2020

Journal Articles

Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty

Ana Belen Moreno-Castaño, MD PhDStudent, Sara Fernandez, MD, Marta Palomo, PhD, Patricia Molina, Technician, Julia Martinez-Sanchez, PhDStudent, Sergi Torramade-Moix, PhDStudent, Helena Ventosa, MD, Ferran Segui, MD, Gines Escolar, MD PhD, Enric Carreras, MD PhD, Jose Maria Nicolas, MD PhD, Edward Richardson, MD, David Garcia-Bernal, PhD, Carmelo Carlo-Stella, MD, Jose Maria Moraleda, MD PhD, Paul G. Richardson, MD, Maribel Diaz-Ricart, Pedro Castro, MD PhD

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-142311

Published: 2020

Journal Articles

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation

Christen L Mumaw, BS, Ayman Akil, PhD, Nieves Velez de Mendizabal, PhD, Qing Zhang, Nisha Raiker, BS, Jeffrey Yu, Maribel Diaz-Ricart, PhD, Enric Carreras, MD, Laura S. Haneline, MD, Kent A. Robertson, MD PhD, Lindsey Elmore, Rose Case, Jamie Renbarger, MD, Samir Hanash, MD PhD, Robert R. Bies, PhD, Sophie Paczesny, MD PhD

Blood (2014) 124 (21): 663.

https://doi.org/10.1182/blood.V124.21.663.663

Published: 2014

Journal Articles

Evidence of Defibrotide Internalization and Its Protective Effect in a Hepatic Endothelial in Vitro model

Maribel Diaz-Ricart, PhD, Marta Palomo, PhD, Enric Mir, PhD, Montserrat Rovira, MD PhD, Gines Escolar, MD PhD, Enric Carreras, MD PhD

Blood (2014) 124 (21): 5960.

https://doi.org/10.1182/blood.V124.21.5960.5960

Published: 2014

Journal Articles

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients

Selim Corbacioglu, MD, Enric Carreras, MD PhD, Mohamad Mohty, MD PhD, Antonio Pagliuca, MD FRCP, FRCPath, Maria Ballabio, MD, Robin L. Hume, MS, Valeria Bandiera, Giorgia Finetto, Paul G. Richardson

Blood (2014) 124 (21): 1138.

https://doi.org/10.1182/blood.V124.21.1138.1138

Published: 2014

Journal Articles

The Combination of the EBMT Score and the HCT-CI Is Not Better Than the HCT-CI Alone in the Prediction of NRM and OS in Patients Undergoing Allogeneic Hematopoietic Transplantation with Reduced-Toxicity Conditioning

Pere Barba, David Valcarcel, MD, Lucía López-Corral, MD, Francesc fernandez-Aviles, Rodrigo Martino, MD, PhD, Monica Cabrero, Montserrat Rovira, jose Luis Pinana, Salut Brunet, Enric Carreras, MD, PhD, maria Dolores Caballero, Jorge Sierra, MD

Blood (2012) 120 (21): 1925.

https://doi.org/10.1182/blood.V120.21.1925.1925

Published: 2012

Journal Articles

Outcome of Second Allogeneic SCT Following Relapse of Hematological Malignancies After a First Allogeneic SCT

Blood (2011) 118 (21): 3056.

https://doi.org/10.1182/blood.V118.21.3056.3056

Published: 2011

Journal Articles

Impact of Different Immunosuppresive Drugs on the Endothelium. Protective Effect of Defibrotide

Maribel Diaz-Ricart, PhD, Alba Carmona, Ph.D., Marta Palomo, Ph.D., Montserrat Rovira, Gines Escolar, MD, PhD, Enric Carreras, MD, PhD

Blood (2011) 118 (21): 5319.

https://doi.org/10.1182/blood.V118.21.5319.5319

Published: 2011

Journal Articles

Stem Cell Transplantation Can Provide Durable Disease Control in Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC): A Retrospective Study From the European Group for Blood and Marrow Transplantation (EBMT)

Blood (2011) 118 (21): 3077.

https://doi.org/10.1182/blood.V118.21.3077.3077

Published: 2011

Journal Articles

Safety of Defibrotide (DF) In Stem Cell Transplant (SCT) Patients (Pts).

Selim Corbacioglu, MD, Enric Carreras, MD, PhD, Dietger W Niederwieser, MD, Marco Sardella, PharmD, Margaret Hoyle, Robin Hume, M.S., Joseph Massaro, Ph.D., Alison L. Hannah, MD, Massimo Iacobelli, MD, Paul G Richardson, Defibrotide Study Group

Blood (2010) 116 (21): 3482.

https://doi.org/10.1182/blood.V116.21.3482.3482

Published: 2010

Journal Articles

Unrelated Cord Blood Transplantation (UCBT) in Adults with MDS or Secondary Acute Myeloblastic Leukemia (sAML): a Survey On Behalf of Eurocord and CLWP of EBMT.

Marie Robin, MD, Guillermo Sanz, Irina Ionescu, Bernard Rio, Anne Sirvent, Marc Renaud, MD, Enric Carreras, MD, PhD, Noel-Jean Milpied, MD, T. M. de Witte, Alessandra Picardi, MD, Eliane Gluckman, Nicolaus Kroger, Vanderson Rocha

Blood (2009) 114 (22): 1198.

https://doi.org/10.1182/blood.V114.22.1198.1198

Published: 2009

Journal Articles

Unrelated Transplants for Poor Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Comparative Analysis Based on the Hematopoietic Progenitor Source.

Blood (2008) 112 (11): 969.

https://doi.org/10.1182/blood.V112.11.969.969

Published: 2008

Journal Articles

Cyclosporine a and Mycophenolate Mofetil Vs Cyclosporine a and Methotrexate as Gvhd Prophylaxis in Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donor.

Jose Luis Piñana, Sr., David Valcarcel, MD, Rodrigo Martino, Francesc Fernandez, Pere Barba, Montserrat Rovira, MD, PhD, Enric Carreras, MD, PhD, Anna Sureda, Jorge Sierra, MD, PhD

Blood (2008) 112 (11): 2229.

https://doi.org/10.1182/blood.V112.11.2229.2229

Published: 2008

Journal Articles

Endothelial Dysfunction in Autologous Hematopoietic Stem Cell Transplantation.

Maribel Diaz-Ricart, PhD, Carla Carbo, Marta Palomo, Francesc Fernandez-Aviles, Montse Rovira, MD, Gines Escolar, MD, Enric Carreras, MD

Blood (2007) 110 (11): 4855.

https://doi.org/10.1182/blood.V110.11.4855.4855

Published: 2007

Journal Articles

Allogeneic SCT with Matched Related and Unrelated Donors for Patients (pts) with Refractory Anemia (RA): Improved Survival after Introduction of Reduced Intensity Conditioning (RIC) Regimens.

T.M. de Witte, MD, Ronald Brand, PhD, Anja van Biezen, Ghulam Mufti, MD, Tapani Ruutu, MD, Jurgen Finke, MD, Peter von dem Borne, MD, Antonin Vitek, MD, Michel Delforge, MD, Paolo E. Alessandrino, MD, Nicholas Harhalakis, MD, Nigel H. Russell, MD, Enric Carreras, MD, Leo F. Verdonck, MD, Dietger W. Niederwieser, MD

Blood (2006) 108 (11): 519.

https://doi.org/10.1182/blood.V108.11.519.519

Published: 2006

Journal Articles

Alterations of ADAMTS-13 Activity as a Common Indicator of the Endothelial Dysfunction Developing in Different Thrombotic Microangiopathies.

Maribel Diaz-Ricart, PhD, Marta Palomo, BSc, Carla Carbo, BSc, Arturo Pereira, MD, Marc Pino, Miquel Lozano, MD, Enric Carreras, MD, Esteban Saperas, MD, Carme Altisent, MD, Jose Aznar-Salati, PhD, Gines Escolar, MD

Blood (2006) 108 (11): 4091.

https://doi.org/10.1182/blood.V108.11.4091.4091

Published: 2006

Journal Articles

Outcomes after HLA-Identical Sibling Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced Intensity Conditioning Compared to Autologous Peripheral Blood Stem Cell Transplantation for Elderly Patients with De Novo Acute Myeloid Leukemia.

Andree-Laure Herr, MD, Myriam Labopin, MD, Didier Blaise, MD, Mike Potter, MD, Felicetto Ferrara, MD, Enric Carreras, MD, William Arcese, MD, Arnon Nagler, MD, Norbert C. Gorin, MD, Francesco Frassoni, MD, Vanderson Rocha, MD, PhD

Blood (2005) 106 (11): 43.

https://doi.org/10.1182/blood.V106.11.43.43

Published: 2005

Journal Articles

Influence of the Intensity of the Conditioning Regimen on the Characteristics of Acute and Chronic Graft Versus Host Disease after Allogeneic Transplantation.

Maria Diez-Campelo, MD, Jose A. Perez-Simon, MD, Rodrigo Martino, MD, Daniel Valcarce, MD, Alvaro Urbano, MD, Dolores M. Caballero, MD, Angel Leon, MD, Salut Brunet, MD, Enric Carreras, MD, Consuelo Maria Cañizo, MD, Jorge Sierra, MD, PhD, Jesus F. San Miguel, MD, PhD

Blood (2004) 104 (11): 5157.

https://doi.org/10.1182/blood.V104.11.5157.5157

Published: 2004

Journal Articles

Donor’s Mannan-Binding Lectin (MBL) Gene Polymorphism Is Associated with Invasive Fungal Infection Following Allogeneic Stem Cell Transplantation.

Miquel Granell, MD, Alvaro Urbano-Ispizua, MD, Francisco Lozano, MD, Montserrat Rovira, MD, Francesc Fernandez-Aviles, MD, Mar Ortega, MD, Carla Uriburu, MD, Carme Talarn, MD, Carmen Martinez, MD, Belen Suarez, Anna Guardia, MD, Enric Carreras, MD, Emili Montserrat, MD

Blood (2004) 104 (11): 2220.

https://doi.org/10.1182/blood.V104.11.2220.2220

Published: 2004

NARROW

Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group

Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation

Evidence of Defibrotide Internalization and Its Protective Effect in a Hepatic Endothelial in Vitro model

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients

The Combination of the EBMT Score and the HCT-CI Is Not Better Than the HCT-CI Alone in the Prediction of NRM and OS in Patients Undergoing Allogeneic Hematopoietic Transplantation with Reduced-Toxicity Conditioning

Outcome of Second Allogeneic SCT Following Relapse of Hematological Malignancies After a First Allogeneic SCT

Impact of Different Immunosuppresive Drugs on the Endothelium. Protective Effect of Defibrotide

Stem Cell Transplantation Can Provide Durable Disease Control in Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC): A Retrospective Study From the European Group for Blood and Marrow Transplantation (EBMT)

Safety of Defibrotide (DF) In Stem Cell Transplant (SCT) Patients (Pts).

Unrelated Cord Blood Transplantation (UCBT) in Adults with MDS or Secondary Acute Myeloblastic Leukemia (sAML): a Survey On Behalf of Eurocord and CLWP of EBMT.

Unrelated Transplants for Poor Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Comparative Analysis Based on the Hematopoietic Progenitor Source.

Cyclosporine a and Mycophenolate Mofetil Vs Cyclosporine a and Methotrexate as Gvhd Prophylaxis in Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donor.

Endothelial Dysfunction in Autologous Hematopoietic Stem Cell Transplantation.

Allogeneic SCT with Matched Related and Unrelated Donors for Patients (pts) with Refractory Anemia (RA): Improved Survival after Introduction of Reduced Intensity Conditioning (RIC) Regimens.

Alterations of ADAMTS-13 Activity as a Common Indicator of the Endothelial Dysfunction Developing in Different Thrombotic Microangiopathies.

Outcomes after HLA-Identical Sibling Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced Intensity Conditioning Compared to Autologous Peripheral Blood Stem Cell Transplantation for Elderly Patients with De Novo Acute Myeloid Leukemia.

Influence of the Intensity of the Conditioning Regimen on the Characteristics of Acute and Chronic Graft Versus Host Disease after Allogeneic Transplantation.

Donor’s Mannan-Binding Lectin (MBL) Gene Polymorphism Is Associated with Invasive Fungal Infection Following Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only